Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biliary Tract Diseases | 1 | 2025 | 22 | 0.240 |
Why?
|
| Endoscopy, Digestive System | 1 | 2025 | 33 | 0.230 |
Why?
|
| Bile Duct Neoplasms | 1 | 2025 | 54 | 0.230 |
Why?
|
| Cholestasis | 1 | 2025 | 65 | 0.230 |
Why?
|
| Celiac Disease | 1 | 2004 | 16 | 0.220 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2004 | 39 | 0.210 |
Why?
|
| Intestine, Small | 1 | 2004 | 79 | 0.210 |
Why?
|
| Stomach Diseases | 1 | 2022 | 10 | 0.190 |
Why?
|
| Artificial Intelligence | 1 | 2025 | 178 | 0.190 |
Why?
|
| Choristoma | 1 | 2022 | 22 | 0.190 |
Why?
|
| Stomach Neoplasms | 1 | 2003 | 78 | 0.190 |
Why?
|
| Rectal Diseases | 1 | 2022 | 28 | 0.190 |
Why?
|
| Pancreatic Fistula | 1 | 2021 | 18 | 0.180 |
Why?
|
| Diaphragm | 1 | 2021 | 22 | 0.180 |
Why?
|
| Immunoconjugates | 1 | 2021 | 90 | 0.170 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2021 | 68 | 0.170 |
Why?
|
| Adenocarcinoma | 1 | 2003 | 342 | 0.160 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2004 | 641 | 0.160 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2017 | 47 | 0.140 |
Why?
|
| Exocrine Pancreatic Insufficiency | 1 | 2016 | 7 | 0.130 |
Why?
|
| Pancreas, Exocrine | 1 | 2016 | 12 | 0.120 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2016 | 64 | 0.120 |
Why?
|
| Pancreatectomy | 1 | 2016 | 101 | 0.120 |
Why?
|
| Islets of Langerhans | 1 | 2016 | 279 | 0.110 |
Why?
|
| Laparoscopy | 1 | 2017 | 491 | 0.100 |
Why?
|
| Pancreatic Neoplasms | 1 | 2016 | 341 | 0.100 |
Why?
|
| Middle Aged | 8 | 2025 | 17562 | 0.090 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2011 | 4 | 0.090 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2011 | 14 | 0.090 |
Why?
|
| Ovarian Neoplasms | 1 | 2011 | 148 | 0.080 |
Why?
|
| Biomarkers, Tumor | 1 | 2011 | 506 | 0.070 |
Why?
|
| Leiomyomatosis | 1 | 2006 | 3 | 0.060 |
Why?
|
| Hormone Antagonists | 1 | 2006 | 12 | 0.060 |
Why?
|
| Humans | 11 | 2025 | 63319 | 0.060 |
Why?
|
| Male | 6 | 2025 | 29840 | 0.060 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2006 | 87 | 0.060 |
Why?
|
| Uterine Neoplasms | 1 | 2006 | 34 | 0.060 |
Why?
|
| Female | 8 | 2025 | 32812 | 0.060 |
Why?
|
| Constriction, Pathologic | 1 | 2025 | 129 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2021 | 1120 | 0.050 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2004 | 74 | 0.050 |
Why?
|
| Biopsy | 1 | 2025 | 444 | 0.050 |
Why?
|
| Biopsy, Needle | 1 | 2004 | 138 | 0.050 |
Why?
|
| Zona Pellucida | 1 | 2003 | 13 | 0.050 |
Why?
|
| Gastritis, Atrophic | 1 | 2003 | 3 | 0.050 |
Why?
|
| CD4 Antigens | 1 | 2004 | 149 | 0.050 |
Why?
|
| Embryo Implantation | 1 | 2003 | 21 | 0.050 |
Why?
|
| Metaplasia | 1 | 2003 | 18 | 0.050 |
Why?
|
| Helicobacter Infections | 1 | 2003 | 55 | 0.050 |
Why?
|
| Helicobacter pylori | 1 | 2003 | 58 | 0.050 |
Why?
|
| Gastric Mucosa | 1 | 2022 | 53 | 0.050 |
Why?
|
| Monitoring, Physiologic | 1 | 2003 | 158 | 0.050 |
Why?
|
| Intestinal Mucosa | 1 | 2004 | 243 | 0.050 |
Why?
|
| Adult | 5 | 2022 | 16796 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 893 | 0.050 |
Why?
|
| Rectum | 1 | 2022 | 89 | 0.050 |
Why?
|
| Tobacco Use | 1 | 2021 | 39 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 973 | 0.040 |
Why?
|
| Salvage Therapy | 1 | 2021 | 75 | 0.040 |
Why?
|
| Risk Factors | 2 | 2016 | 5345 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2004 | 1542 | 0.040 |
Why?
|
| Disease Progression | 1 | 2003 | 1171 | 0.040 |
Why?
|
| Alcoholism | 1 | 2021 | 318 | 0.040 |
Why?
|
| Operative Time | 1 | 2017 | 92 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 447 | 0.030 |
Why?
|
| Gastric Bypass | 1 | 2017 | 76 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2021 | 863 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 1616 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2016 | 59 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2016 | 88 | 0.030 |
Why?
|
| Aged | 2 | 2025 | 14400 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2017 | 6642 | 0.030 |
Why?
|
| Length of Stay | 1 | 2017 | 811 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2016 | 219 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2016 | 872 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2011 | 39 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2016 | 5664 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2011 | 301 | 0.020 |
Why?
|
| Proteomics | 1 | 2011 | 283 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 3763 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2006 | 69 | 0.020 |
Why?
|
| Uterus | 1 | 2006 | 42 | 0.020 |
Why?
|
| Organ Size | 1 | 2006 | 172 | 0.020 |
Why?
|
| Hysterectomy | 1 | 2006 | 69 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 5449 | 0.020 |
Why?
|
| Young Adult | 1 | 2016 | 4687 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2006 | 192 | 0.010 |
Why?
|
| Animals | 1 | 2003 | 20616 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2006 | 738 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 860 | 0.010 |
Why?
|
| Isotonic Solutions | 1 | 2003 | 14 | 0.010 |
Why?
|
| Sperm Injections, Intracytoplasmic | 1 | 2003 | 32 | 0.010 |
Why?
|
| Blastocyst | 1 | 2003 | 72 | 0.010 |
Why?
|
| Pregnancy | 1 | 2003 | 2335 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2003 | 3285 | 0.010 |
Why?
|